Molecular Imaging: Page 35

10 years on, PET/MRI begins to deliver in clinical arena

By Will Morton

A wide-ranging and timely special focus session held at ECR 2021 looked at the status of PET/MRI and the progress made over the past decade. Where are we now with "the prince that was promised"?

March 17, 2021

AI reduces FDG dose on PET imaging

By Kate Madden Yee

A European team of researchers has found that an artificial intelligence (AI) algorithm can process F-18 FDG PET exams acquired at two-thirds of the standard radiopharmaceutical dose and produce diagnostically effective images, according to a study published on 9 March in EJNMMI Physics.

March 11, 2021

Tributes flow in for MRI and PET pioneer John Mallard

By AuntMinnieEurope.com staff writers

Medical physicist John Mallard, PhD, a pioneering researcher in MRI and early advocate of PET, has died at the age of 94, according to the University of Aberdeen in Scotland.

March 8, 2021

Whole-body MRI helps cancer patients where FDG-PET fails

By Wayne Forrest

FDG-PET/CT is the modality of choice for staging and assessing cancer patients, but whole-body MRI can make a valuable contribution to detection and diagnoses where the hybrid modality underperforms, ECR 2021 registrants learned at a special session on Sunday evening.

March 7, 2021

Telix secures Czech approval for prostate PET radiopharmaceutical

By AuntMinnieEurope.com staff writers

Telix Pharmaceuticals has received approval from the Czech Republic's Ministry of Health for use of its Illuccix radiopharmaceutical for prostate cancer PET imaging in that country.

February 18, 2021

Spanish researchers tie midlife heart disease to Alzheimer's

By Brian Casey

Researchers from Spain have used PET to discover that individuals in their 50s with signs of cardiovascular disease also have reduced brain metabolism in areas connected with Alzheimer's disease. The findings provide a link between brain and heart health.

February 16, 2021

Nano-MRI outduels PSMA-PET/CT for prostate cancer

By Wayne Forrest

Clinicians looking to accurately classify suspicious lymph nodes in prostate cancer patients could have another effective noninvasive option with a unique contrast-enhanced MR imaging technique, according to a study published online on 30 January in the Journal of Nuclear Medicine.

February 11, 2021

Russians eye radiopharmaceuticals with metal

By AuntMinnieEurope.com staff writers

Metal-containing radiopharmaceuticals are highly effective at detecting early markers of Alzheimer's disease, and they are synchrotron-independent and long-lived, according to a new review by Russian researchers.

February 10, 2021

EANM launches extremity dose survey

By AuntMinnieEurope.com staff writers

The European Association of Nuclear Medicine (EANM) has launched a survey to explore how different European countries use nuclear medicine extremity dose guidelines and dosimeters.

February 7, 2021

Aikido invests in U.K. prostate radiopharma firm

By AuntMinnieEurope.com staff writers

Aikido Pharma has made an investment in Convergent Therapeutics, a company developing a radiopharmaceutical for treating prostate cancer. Aikido made the investment in the form of a $2 million (1.7 million euros) convertible promissory note purchase agreement.

February 2, 2021

Higher radiation can improve outcome in lung cancer

By Rebekah Moan

Dutch and U.S. groups reported new research findings from two studies about the use of higher radiation boost doses for lung cancer at the International Association for the Study of Lung Cancer world conference. The virtual event wrapped up on 31 January.

February 2, 2021

EANM unveils supplier audit initiative

By AuntMinnieEurope.com staff writers

The European Association of Nuclear Medicine (EANM) Research has launched a supplier audit program, along with three new PET/CT accreditations.

January 28, 2021

Previous Page

Page 35 of 121

Next Page